Menopausal stages and non-alcoholic fatty liver disease in middle-aged women

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 190, Issue , 2015, Pages 65-70

  Ryu, Seungho ^a   Suh, Byung Seong ^a   Chang, Yoosoo ^a   Kwon, Min Jung ^a   Yun, Kyung Eun ^a   Jung, Hyun Suk ^a   Kim, Chan Won ^a   Kim, Bo Kyoung ^a   Kim, Yoo Jin ^a   Choi, Yuni ^a   Ahn, Jiin ^a   Cho, Yong Kyun ^a   Kim, Kye Hyun ^a   Ahn, Younjhin ^b   Park, Hyun Young ^b   Chung, Eun Chul ^a   Shin, Hocheol ^a   Cho, Juhee ^a,c  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Korea National Institute of Health   (South Korea)

^c Sungkyunkwan University   (South Korea)

Author keywords

Menopausal transition; Menopause; NAFLD; Obesity

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; C REACTIVE PROTEIN; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT; TRIACYLGLYCEROL; URIC ACID;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALCOHOL CONSUMPTION; AMENORRHEA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLIMACTERIUM; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; EDUCATIONAL STATUS; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; MASS SCREENING; MENARCHE; MENOPAUSE; MENSTRUAL CYCLE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PARITY; PHYSICAL ACTIVITY; POSTMENOPAUSE; PRIORITY JOURNAL; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL; URIC ACID BLOOD LEVEL; NON-ALCOHOLIC FATTY LIVER DISEASE; PREMENOPAUSE; PREVALENCE; SOUTH KOREA;

ADULT; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; MIDDLE AGED; NON-ALCOHOLIC FATTY LIVER DISEASE; PERIMENOPAUSE; POSTMENOPAUSE; PREMENOPAUSE; PREVALENCE; REPUBLIC OF KOREA;

EID: 84930688943     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2015.04.017     Document Type: Article

References (43)

1. M. Lazo, and J.M. Clark The epidemiology of nonalcoholic fatty liver disease: a global perspective Semin Liver Dis 28 2008 339 350
2. L.A. Adams, S. Sanderson, K.D. Lindor, and P. Angulo The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies J Hepatol 42 2005 132 138
3. S.H. Caldwell, and D.M. Crespo The spectrum expanded: cryptogenic cirrhosis and the natural history of non-alcoholic fatty liver disease J Hepatol 40 2004 578 584
4. M.S. Ascha, I.A. Hanouneh, R. Lopez, T.A. Tamimi, A.F. Feldstein, and N.N. Zein The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis Hepatology 51 2010 1972 1978
5. G. Marchesini, R. Marzocchi, F. Agostini, and E. Bugianesi Nonalcoholic fatty liver disease and the metabolic syndrome Curr Opin Lipidol 16 2005 421 427
6. J.G. Fan, and Y.D. Peng Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies Hepatobiliary Pancreat Dis Int 6 2007 572 578
7. S. Chitturi, and G.C. Farrell Fatty liver now, diabetes and heart attack later? The liver as a barometer of metabolic health J Gastroenterol Hepatol 22 2007 967 969
8. G. Targher, and G. Arcaro Non-alcoholic fatty liver disease and increased risk of cardiovascular disease Atherosclerosis 191 2007 235 240
9. S.H. Park, W.K. Jeon, and S.H. Kim Prevalence and risk factors of non-alcoholic fatty liver disease among Korean adults J Gastroenterol Hepatol 21 2006 138 143
10. J.M. Clark, F.L. Brancati, and A.M. Diehl The prevalence and etiology of elevated aminotransferase levels in the United States Am J Gastroenterol 98 2003 960 967
11. A. Fraser, M.P. Longnecker, and D.A. Lawlor Prevalence of elevated alanine aminotransferase among US adolescents and associated factors: NHANES 1999-2004 Gastroenterology 133 2007 1814 1820
12. S. Zelber-Sagi, D. Nitzan-Kaluski, Z. Halpern, and R. Oren Prevalence of primary non-alcoholic fatty liver disease in a population-based study and its association with biochemical and anthropometric measures Liver Int 26 2006 856 863
13. Y.J. Zhou, Y.Y. Li, and Y.Q. Nie Prevalence of fatty liver disease and its risk factors in the population of South China World J Gastroenterol 13 2007 6419 6424
14. S. Kojima, N. Watanabe, M. Numata, T. Ogawa, and S. Matsuzaki Increase in the prevalence of fatty liver in Japan over the past 12 years: analysis of clinical background J Gastroenterol 38 2003 954 961
15. J.M. Clark, F.L. Brancati, and A.M. Diehl Nonalcoholic fatty liver disease Gastroenterology 122 2002 1649 1657
16. H. Volzke, S. Schwarz, and S.E. Baumeister Menopausal status and hepatic steatosis in a general female population Gut 56 2007 594 595
17. Y. Gutierrez-Grobe, G. Ponciano-Rodriguez, M.H. Ramos, M. Uribe, and N. Mendez-Sanchez Prevalence of non alcoholic fatty liver disease in premenopausal, postmenopausal and polycystic ovary syndrome women. The role of estrogens Ann Hepatol 9 2010 402 409
18. S. Bruno, P. Maisonneuve, and P. Castellana Incidence and risk factors for non-alcoholic steatohepatitis: prospective study of 5408 women enrolled in Italian tamoxifen chemoprevention trial BMJ 330 2005 932
19. G.S. Florentino, H.P. Cotrim, C.P. Vilar, A.V. Florentino, G.M. Guimaraes, and V.S. Barreto Nonalcoholic fatty liver disease in menopausal women Arq Gastroenterol 50 2013 180 185
20. S.D. Harlow, M. Gass, and J.E. Hall Executive summary of the Stages of Reproductive Aging Workshop +10: addressing the unfinished agenda of staging reproductive aging J Clin Endocrinol Metab 97 2012 1159 1168
21. Y. Chang, B.K. Kim, and K.E. Yun Metabolically-healthy obesity and coronary artery calcification J Am Coll Cardiol 63 2014 2679 2686
22. N. Chalasani, Z. Younossi, and J.E. Lavine The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association Hepatology 55 2012 2005 2023
23. C.L. Craig, A.L. Marshall, and M. Sjostrom International physical activity questionnaire: 12-country reliability and validity Med Sci Sports Exerc 35 2003 1381 1395
24. J.Y. Oh, Y.J. Yang, B.S. Kim, and J.H. Kang Validity and reliability of Korean version of International Physical Activity Questionnaire (IPAQ) short form Korean J Fam Med 28 2007 532 541
25. U.L. Mathiesen, L.E. Franzen, and H. Aselius Increased liver echogenicity at ultrasound examination reflects degree of steatosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases Digest Liver Dis 34 2002 516 522
26. C.W. Kim, K.E. Yun, and H.S. Jung Sleep duration and quality in relation to non-alcoholic fatty liver disease in middle-aged workers and their spouses J Hepatol 59 2013 351 357
27. G.X. Tian, Y. Sun, and C.J. Pang Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men Obesity Rev 13 2012 381 387
28. M.R. Sowers, H. Zheng, D. McConnell, B. Nan, S.D. Harlow, and J.F. Randolph Jr. Estradiol rates of change in relation to the final menstrual period in a population-based cohort of women J Clin Endocrinol Metab 93 2008 3847 3852
29. M.C. Carr The emergence of the metabolic syndrome with menopause J Clin Endocrinol Metab 88 2003 2404 2411
30. H.N. Polotsky, and A.J. Polotsky Metabolic implications of menopause Semin Reprod Med 28 2010 426 434
31. K.L. Donnelly, C.I. Smith, S.J. Schwarzenberg, J. Jessurun, M.D. Boldt, and E.J. Parks Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease J Clin Invest 115 2005 1343 1351
32. G. Marchesini, S. Moscatiello, S. Di Domizio, and G. Forlani Obesity-associated liver disease J Clin Endocrinol Metab 93 2008 S74 S80
33. Y.W. Park, S. Zhu, L. Palaniappan, S. Heshka, M.R. Carnethon, and S.B. Heymsfield The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994 Arch Intern Med 163 2003 427 436
34. P.W. Wilson, W.B. Kannel, H. Silbershatz, and R.B. D'Agostino Clustering of metabolic factors and coronary heart disease Arch Intern Med 159 1999 1104 1109
35. C.M. Masi, L.C. Hawkley, X. Xu, T.D. Veenstra, and J.T. Cacioppo Serum estrogen metabolites and systolic blood pressure among middle-aged and older women and men Am J Hypertens 22 2009 1148 1153
36. D. Preiss, and N. Sattar Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations Clin Sci 115 2008 141 150
37. I. Shimizu, N. Kohno, and K. Tamaki Female hepatology: favorable role of estrogen in chronic liver disease with hepatitis B virus infection World J Gastroenterol 13 2007 4295 4305
38. N. Mendez-Sanchez, M. Arrese, D. Zamora-Valdes, and M. Uribe Current concepts in the pathogenesis of nonalcoholic fatty liver disease Liver Int 27 2007 423 433
39. P.G. Tepper, J.F. Randolph Jr., and D.S. McConnell Trajectory clustering of estradiol and follicle-stimulating hormone during the menopausal transition among women in the Study of Women's Health across the Nation (SWAN) J Clin Endocrinol Metab 97 2012 2872 2880
40. D. Joy, V.R. Thava, and B.B. Scott Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 15 2003 539 543
41. A.J. Sanyal, and A. American Gastroenterological AGA technical review on nonalcoholic fatty liver disease Gastroenterology 123 2002 1705 1725
42. J.M. Clark, and A.M. Diehl Defining nonalcoholic fatty liver disease: implications for epidemiologic studies Gastroenterology 124 2003 248 250
43. S. Bellentani, and C. Tiribelli The spectrum of liver disease in the general population: lesson from the Dionysos study J Hepatol 35 2001 531 537